BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6327570)

  • 1. [The glucagonoma syndrome--a not-so-well-known cutaneous paraneoplastic condition. Case report].
    Galle K; Schweiss D
    Hautarzt; 1984 Apr; 35(4):204-9. PubMed ID: 6327570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of glucagonoma-related necrolytic migratory erythema with dacarbazine.
    van der Loos TL; Lambrecht ER; Lambers JC
    J Am Acad Dermatol; 1987 Feb; 16(2 Pt 2):468-72. PubMed ID: 3029193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucagonoma syndrome. Unusual histologic image].
    Poiares Baptista A; Tellechea O; Aguiar M; Leitão A
    Ann Dermatol Venereol; 1987; 114(1):55-8. PubMed ID: 3034125
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metastatic glucagonoma. Complete remission by dacarbazine (5 years' recession)].
    Jeanmougin M; Civatte J; Bonvalet D; Passa P; Verola O; Zylberait D
    Ann Dermatol Venereol; 1988; 115(8):833-8. PubMed ID: 2849362
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glucagonoma with diabetic ketoacidosis; case report].
    Lefebvre J; Lelièvre G; Dalle-Furnari MA; Proye C; Mazzuca M; Garraud JC; Luyckx A; Linquette M
    Diabete Metab; 1982 Sep; 8(3):191-5. PubMed ID: 6292011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare combination consisting of primary hyperaldosteronism and glucagonoma.
    Abe H; Kubota K; Noie T; Kimura W; Makuuchi M
    Am J Gastroenterol; 1999 May; 94(5):1397-401. PubMed ID: 10235226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural studies of necrolytic migratory erythema.
    Ohyama K; Kitoh M; Arao T
    Arch Dermatol; 1982 Sep; 118(9):679-82. PubMed ID: 6287944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glucagonoma syndrome].
    Picard C; Mazer JM; Bilet S; Villette B; Penchet A; Toublanc M; Grossin M; Debussche X; Assan R; Belaïch S
    Ann Dermatol Venereol; 1988; 115(11):1142-5. PubMed ID: 2853600
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of somatostatin on skin lesions and concentrations of plasma amino acids in a patient with glucagonoma-syndrome.
    Schmid R; Allescher HD; Schepp W; Hölscher A; Siewert R; Schusdziarra V; Classen M
    Hepatogastroenterology; 1988 Feb; 35(1):34-7. PubMed ID: 2896149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Necrolytic migratory erythema: glucagonoma syndrome. Clinical and histological aspects].
    Wilkinson DS
    Ann Med Interne (Paris); 1984; 135(8):654-7. PubMed ID: 6099068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrobulbar neuritis as the first sign of the glucagonoma syndrome.
    Lambrecht ER; van der Loos TL; van der Eerden AH
    Int Ophthalmol; 1987 Oct; 11(1):13-5. PubMed ID: 2826358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses.
    Moattari AR; Cho K; Vinik AI
    Surgery; 1990 Sep; 108(3):581-7. PubMed ID: 2168587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience in diagnosis and treatment of glucagonoma syndrome.
    Zhang M; Xu X; Shen Y; Hu ZH; Wu LM; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):473-5. PubMed ID: 15313692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant endocrine tumor of the pancreas and ensuing clinical syndromes].
    Boumghar M
    J Chir (Paris); 1988 Mar; 125(3):174-7. PubMed ID: 2836444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Necrolytic migratory erythema.
    Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
    J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glucagonoma syndrome. Clinico-therapeutic data relative to personal experience and review of the literature].
    Biliotti GC; Vestrini G; Tonelli P; Vallecchi C
    Minerva Chir; 1989 Jan; 44(1-2):163-72. PubMed ID: 2540454
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glucagonoma syndrome. Apropos of a case without diabetes. Review of the literature].
    Pizzi M; Weiller M; Lansman V; Scheiner C; Dor AM; Lebreuil G
    Sem Hop; 1983 May; 59(20):1533-40. PubMed ID: 6308776
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study.
    Vandersteen PR; Scheithauer BW
    J Am Acad Dermatol; 1985 Jun; 12(6):1032-9. PubMed ID: 2989344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Iatrogenic glucagonoma syndrome?].
    Benhamou PY; Reymond JL; Boizel R; Béani JC; Amblard P
    Ann Dermatol Venereol; 1988; 115(6-7):717-9. PubMed ID: 2849361
    [No Abstract]   [Full Text] [Related]  

  • 20. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma.
    Technau K; Renkl A; Norgauer J; Ziemer M
    Eur J Dermatol; 2005; 15(2):110-2. PubMed ID: 15757825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.